2024 American Academy of Neurology Abstract Website

Disclosures for "Lifesaving Treatments for Spinal Muscular Atrophy: Global Access and Availability"

Dr. Armengol has nothing to disclose.
The institution of Dr. Darras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Darras has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. The institution of Dr. Darras has received research support from National Institutes of Health/National Institute of Neurological Disorders and Stroke,. The institution of Dr. Darras has received research support from Slaney Family Fund for SMA. The institution of Dr. Darras has received research support from Spinal Muscular Atrophy Foundation. The institution of Dr. Darras has received research support from CureSMA. The institution of Dr. Darras has received research support from Working on Walking Fund . The institution of Dr. Darras has received research support from CHERISH, CS2/CS12 . The institution of Dr. Darras has received research support from Biogen for CS11. The institution of Dr. Darras has received research support from AveXis. The institution of Dr. Darras has received research support from Sarepta Pharmaceuticals. The institution of Dr. Darras has received research support from PTC Therapeutics. The institution of Dr. Darras has received research support from Roche. The institution of Dr. Darras has received research support from Santhera. The institution of Dr. Darras has received research support from Scholar Rock. The institution of Dr. Darras has received research support from Fibrogen. The institution of Dr. Darras has received research support from Summit. Dr. Darras has received publishing royalties from a publication relating to health care. Dr. Darras has received publishing royalties from a publication relating to health care.
Dr. Abulaban has nothing to disclose.
Dr. Alshehri has nothing to disclose.
The institution of Dr. Barisic has received personal compensation in the range of $0-$499 for serving as a Consultant for roche. The institution of Dr. Barisic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis.
Ben-Omran Tawfeg has nothing to disclose.
Dr. Castiglioni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Castiglioni has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for PTC.
Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Avexis/Norvatis. Yin-Hsiu Chien has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Yin-Hsiu Chien has received research support from Sanofi Genzyme.
Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Michelle A. Farrar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Michelle A. Farrar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Dr. Kandawasvika has nothing to disclose.
Satish Khadilkar has nothing to disclose.
Dr. Mah has nothing to disclose.
Chiara Marini-Bettolo has nothing to disclose.
Prof. Osredkr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Novartis, Roche. Prof. Osredkr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, Biogen, Roche.
Dr. Pfeffer has received research support from Canadian Institutes of Health Research.
Dr. Piazzon has nothing to disclose.
Dr. Pitarch Castellano has nothing to disclose.
Prof. Quijano-Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Prof. Quijano-Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis GT. Prof. Quijano-Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAnofi Genzyme. Prof. Quijano-Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Prof. Quijano-Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AVEXIS. Prof. Quijano-Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Prof. Quijano-Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Quijano-Roy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS GT. Prof. Quijano-Roy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Prof. Quijano-Roy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis GT. Prof. Quijano-Roy has received publishing royalties from a publication relating to health care.
Dr. Saito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Gene Therapies, Inc./Novartis. Dr. Saito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Saito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai (Roche). Dr. Saito has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis Gene Therapies, Inc./Novartis. Dr. Saito has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Chugai (Roche). The institution of Dr. Saito has received research support from Biogen.
Dr. Shin has nothing to disclose.
Dr. Vázquez Costa has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen and Roche. The institution of Dr. Vázquez Costa has received research support from Roche.
Prof. Walter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC. Prof. Walter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Prof. Walter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Prof. Walter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Edgewise. Prof. Walter has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Walter has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Walter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Prof. Walter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Prof. Walter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharnext. Prof. Walter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PTC. Prof. Walter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche.
Prof. Wanigasinghe has nothing to disclose.
Hui Xiong has nothing to disclose.
Dr. Griggs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Strongbridge Pharmaceuticals. Dr. Griggs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idera Pharmaceuticals. Dr. Griggs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biopharma. Dr. Griggs has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Santhera Pharmaceuticals. Dr. Griggs has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Griggs has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Lippincott. The institution of Dr. Griggs has received research support from PTC Pharmaceuticals. The institution of Dr. Griggs has received research support from Sarepta Pharmaceuticals. The institution of Dr. Griggs has received research support from National Institutes of Health. The institution of Dr. Griggs has received research support from Santhere Pharmaceuticals. Dr. Griggs has received personal compensation in the range of $500-$4,999 for serving as a Study section member with National Institutes of Health. Dr. Griggs has a non-compensated relationship as a Board of Directors;Chair Research Advisory Committee with American Brain Foundation that is relevant to AAN interests or activities.
Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda Pharmaceuticals. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has stock in Cabaletta bio. . The institution of Dr. Roy has received research support from Martin Shubik Fund for IBM at Yale University. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals.